0000899243-19-026639.txt : 20191105
0000899243-19-026639.hdr.sgml : 20191105
20191105060843
ACCESSION NUMBER: 0000899243-19-026639
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191104
FILED AS OF DATE: 20191105
DATE AS OF CHANGE: 20191105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Snisarenko John
CENTRAL INDEX KEY: 0001783264
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39112
FILM NUMBER: 191191639
MAIL ADDRESS:
STREET 1: C/O ALIMERA SCIENCES, INC.
STREET 2: 6120 WINDWARD PARKWAY, SUITE 290
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oyster Point Pharma, Inc.
CENTRAL INDEX KEY: 0001720725
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 811030955
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 202 CARNEGIE CENTER
STREET 2: SUITE 109
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: (609) 382-9032
MAIL ADDRESS:
STREET 1: 202 CARNEGIE CENTER
STREET 2: SUITE 109
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-04
0
0001720725
Oyster Point Pharma, Inc.
OYST
0001783264
Snisarenko John
C/O OYSTER POINT PHARMA, INC.
202 CARNEGIE CENTER, SUITE 109
PRINCETON
NJ
08540
0
1
0
0
Chief Commercial Officer
Common Stock, par value $0.001 per share
2019-11-04
4
P
0
3000
16.00
A
3000
D
/s/Jeffrey Nau, Attorney-in-fact
2019-11-04